View in EDS HTML Full Text PDF Full Text

Clinical study of aumolertinib versus osimertinib in the treatment of EGFR-mutated advanced non-small cell lung cancer.

Saved in:
Bibliographic Details
Title: Clinical study of aumolertinib versus osimertinib in the treatment of EGFR-mutated advanced non-small cell lung cancer.
Authors: Yang SX; Department of Clinical Pharmacy, The First People's Hospital of Yunnan Province/The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032, China., Zhu JD; Department of Pharmacy, The People's Hospital of Yongshan County, Zhaotong, 657300, China., Ma L; Department of Clinical Pharmacy, The First People's Hospital of Yunnan Province/The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032, China., Pan Y; Department of Clinical Pharmacy, The First People's Hospital of Yunnan Province/The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032, China., Li QR; Department of Pharmacy, The People's Hospital of Chuxiong Yi Autonomo, Chuxiong, 675000, China., Tu WL; Department of Clinical Pharmacy, The First People's Hospital of Yunnan Province/The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032, China. tuwenlian18@aliyun.com., Zhang ZQ; Department of Clinical Pharmacy, The First People's Hospital of Yunnan Province/The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032, China. 564267128@qq.com.
Source: Discover oncology [Discov Oncol] 2025 Oct 06; Vol. 16 (1), pp. 1818. Date of Electronic Publication: 2025 Oct 06.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2730-6011
DOI:10.1007/s12672-025-03642-5